ViciniVax BV

Private

GroningenHealthcare & Life Scienceshttps://vicinivax.com/

Last Round

VC Round

Jul 1, 2026

Company Overview

ViciniVax BV is a clinical-stage biopharmaceutical company that develops therapeutic cancer vaccines for the treatment of HPV-related premalignant lesions and cervical cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cancer vaccineimmunotherapyHPV vaccinecancer immunotherapycervical cancer treatmentRNA repliconbiopharmaceuticalclinical trialhuman papillomavirusHPVCIN2/3cervical intraepithelial neoplasiatherapeutic vaccineviral vectorbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViciniVax BV Comparables

Compare ViciniVax BV with similar companies based on industry and business-model similarity.

ViciniVax BV comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Barinthus Biotherapeutics	78%
PDS Biotechnology Corp	78%
Nykode Therapeutics	77%

View all Comparables

ViciniVax BV Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jul 1, 2026

View all Funding Rounds

ViciniVax BV Investors

Notable investors and investment history

ViciniVax BV investors
Investor	Rounds
RuG Ventures	Seed
Hanzepoort B.V.	Seed

View all Investors

ViciniVax BV Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ViciniVax BV Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViciniVax BV's valuation, stock price, and market status.

Firmographic Details

HeadquartersGroningen

Employee Range2

Year Founded2008

Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.